A mutation in the gene for rhodopsin corresponding to a substitution of glycine 90 by aspartic acid (G90D) is found in one form of congenital night blindness, and the corresponding amino acid replacement was introduced into rhodopsin for in vitro molecular studies. This evidence concerns the gene RHO and congenital stationary night blindness.